Treffer 1 - 3 von 3 für Suche 'Homayr, Anna', Suchdauer: 0,67s Treffer weiter einschränken
  1. 1
    Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

    Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells von Uthman, Laween, Homayr, Anna, Juni, Rio P, Spin, Eva L, Kerindongo, Raphaela, Boomsma, Marleen, Hollmann, Markus W, Preckel, Benedikt, Koolwijk, Pieter, van Hinsbergh, Victor W M, Zuurbier, Coert J, Albrecht, Martin, Weber, Nina C


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    What the clinician needs to know about medical nutrition therapy in critically ill patients in 2023: A narrative review

    What the clinician needs to know about medical nutrition therapy in critically ill patients in 2023: A narrative review von Dresen, Ellen, Notz, Quirin, Menger, Johannes, Homayr, Anna L., Lindner, Matthias, Radke, David I., Stoppe, Christian, Elke, Gunnar

    Veröffentlicht in Nutrition in clinical practice

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Administration of SGLT2 inhibitor empagliflozin against TNF‐α induced endothelial dysfunction in human venous and arterial endothelial cells

    Administration of SGLT2 inhibitor empagliflozin against TNF‐α induced endothelial dysfunction in human venous and arterial endothelial cells von Uthman, Laween, Homayr, Anna, Hollmann, Markus W., Zuurbier, Coert J., Weber, Nina C.

    Veröffentlicht in The FASEB journal

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: